CABAZITAXEL Spirig HC conc perf 60 mg/3ml flac
7680689590011
CH-68959
L01CD04
07.16.1.
Reimbursement limitations:
CABAZ.SPI.02
En association avec la prednisone ou la prednisolone, pour le traitement de patients atteints d'un …
1 / 3
google
Details
- Product number
- 6895901
- CPT
- -
- Packaging group
- 3
- Unit
- ml
- Composition
- cabazitaxelum 60 mg, polysorbatum 80, ethanolum anhydricum 1185 mg, acidum citricum, pro vitro.
Articles (1)
Cabazitaxel Spirig HC 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1185.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2690.90
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/11/2023
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 68959
- Drug name
- Cabazitaxel Spirig HC, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CD04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/12/2022
- Authorization expiration date
- 30/11/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CABAZITAXEL Spirig HC conc perf 60 mg/3ml flac
- Description (DE)
- CABAZITAXEL Spirig HC Inf Konz 60 mg/3ml Durchstf
- Market launch
- 01/12/2022
- Narcotic (BTM)
- No